1. Home
  2. MVBF vs IPSC Comparison

MVBF vs IPSC Comparison

Compare MVBF & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MVB Financial Corp.

MVBF

MVB Financial Corp.

HOLD

Current Price

$24.96

Market Cap

329.1M

Sector

Finance

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.15

Market Cap

370.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MVBF
IPSC
Founded
1997
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
329.1M
370.2M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
MVBF
IPSC
Price
$24.96
$2.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$27.60
$3.50
AVG Volume (30 Days)
26.6K
1.4M
Earning Date
04-29-2026
05-14-2026
Dividend Yield
2.74%
N/A
EPS Growth
34.64
91.30
EPS
2.06
N/A
Revenue
$3,400,000.00
$109,164,000.00
Revenue This Year
$1.70
N/A
Revenue Next Year
$13.59
N/A
P/E Ratio
$12.06
N/A
Revenue Growth
51.92
1556.76
52 Week Low
$15.59
$0.34
52 Week High
$29.59
$2.97

Technical Indicators

Market Signals
Indicator
MVBF
IPSC
Relative Strength Index (RSI) 41.73 46.07
Support Level $22.50 $0.49
Resistance Level $25.00 $2.68
Average True Range (ATR) 0.71 0.21
MACD 0.08 -0.04
Stochastic Oscillator 45.50 27.18

Price Performance

Historical Comparison
MVBF
IPSC

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: